advertisement
Mastropasqua R 20
Showing records 1 to 20 | Display all abstracts from Mastropasqua R126588 Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
Agnifili L
Scientific reports 2025; 15: 12980
126187 Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy
Sacchi M
International journal of molecular sciences 2025; 26:
126588 Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
Ruggeri ML
Scientific reports 2025; 15: 12980
126187 Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy
Tomaselli D
International journal of molecular sciences 2025; 26:
126588 Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
Figus M
Scientific reports 2025; 15: 12980
126187 Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy
Ruggeri ML
International journal of molecular sciences 2025; 26:
126588 Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
Corboli LV
Scientific reports 2025; 15: 12980
126187 Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy
Aiello FB
International journal of molecular sciences 2025; 26:
126588 Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
Fornaro M
Scientific reports 2025; 15: 12980
126187 Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy
Sabella P
International journal of molecular sciences 2025; 26:
126588 Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
Covello G
Scientific reports 2025; 15: 12980
126187 Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy
Dore S
International journal of molecular sciences 2025; 26:
126588 Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
Mastropasqua R
Scientific reports 2025; 15: 12980
126187 Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy
Pinna A
International journal of molecular sciences 2025; 26:
126588 Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
Di Nicola M
Scientific reports 2025; 15: 12980
126187 Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy
Mastropasqua R
International journal of molecular sciences 2025; 26:
126588 Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
Marotta A
Scientific reports 2025; 15: 12980
126187 Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy
Nubile M
International journal of molecular sciences 2025; 26:
126588 Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
Mastropasqua L
Scientific reports 2025; 15: 12980
126187 Fighting Bleb Fibrosis After Glaucoma Surgery: Updated Focus on Key Players and Novel Targets for Therapy
Agnifili L
International journal of molecular sciences 2025; 26:
